Studies in CRC have indicated that upregulation of TIMP1 was associated with poor prognosis and confirmed that TIMP1 can promote tumor cell proliferation and metastasis through the FAK/Akt signaling pathway (22, 25). This evidence concerns the gene PTK2 and colorectal carcinoma.